Methodology and Indications of H₂-Breath Testing in Gastrointestinal Diseases: The Rome Consensus ConferenceGASBARRINI, A; CORAZZA, G. R.Alimentary pharmacology & therapeutics. Supplement. 2009, Vol 29, Num 1, issn 0953-0673, 50 p.Serial Issue

Your IBD Patient: Challenges and Advances in Patient CareTRAVIS, S. P. L.Alimentary pharmacology & therapeutics. Supplement. 2008, Vol 27, Num 1, issn 0953-0673, 24 p.Conference Proceedings

Review article : the burden of hepatic encephalopathyPOORDAD, F. F.Alimentary pharmacology & therapeutics. Supplement. 2007, Vol 25, Num 1, pp 3-9, issn 0953-0673, 7 p.Article

Review article : pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infectionAFDHAL, N. H; MCHUTCHISON, J. G.Alimentary pharmacology & therapeutics. Supplement. 2007, Vol 26, Num 1, pp 29-39, issn 0953-0673, 11 p.Article

Modern technology in the diagnosis of gastro-oesophageal reflux disease : Bilitec, intraluminal impedance and Bravo capsule pH monitorinqHIRANO, I.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 23, Num 1, pp 12-24, issn 0953-0673, 13 p.Article

New approaches to the detection and management of inflammatory bowel disease: From genetic testing to treatment strategiesGASSULL, M. A; OBRADOR, A.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 3, issn 0953-0673, 97 p.Serial Issue

Review article : capsule endoscopy - are all small intestinal lesions Crohn's disease?BAR-MEIR, S.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 3, pp 19-21, issn 0953-0673, 3 p.Article

Review article : what are the important endoscopic lesions for detection of dysplasia in inflammatory bowel disease?GEBOES, K.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 3, pp 50-55, issn 0953-0673, 6 p.Article

Review article : the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel diseaseSTANGE, E. F.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 3, pp 64-67, issn 0953-0673, 4 p.Article

Review article : human pepsins - their multiplicity, function and rôle in reflux diseaseROBERTS, N. B.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 24, Num 2, pp 2-9, issn 0953-0673, 8 p.Article

Usefulness of famotidine in functional dyspepsia patient treatment : comparison among prokinetic, acid suppression and antianxiety therapiesSENO, H; NAKASE, H; CHIBA, T et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 21, Num 2, pp 32-36, issn 0953-0673, 5 p.Article

Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcerKAMADA, T; HATA, J; TANIMOTO, T et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 21, Num 2, pp 73-78, issn 0953-0673, 6 p.Article

Prevention of the rehaemorrhage of bleeding peptic ulcers : effects of Helicobacter pylori eradication and acid suppressionKIKKAWA, A; IWAKIRI, R; FUJIMOTO, K et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 21, Num 2, pp 79-84, issn 0953-0673, 6 p.Article

Role of pepsin and bile in gastro-oesophageal reflux diseaseTACK, J.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 48-54, issn 0953-0673, 7 p.Article

Chronic hepatitis C : natural history and cofactorsALBERTI, A; VARIO, A; FERRARI, A et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 2, pp 74-78, issn 0953-0673, 5 p.Article

Immediate-release proton-pump inhibitor therapy : potential advantagesHOWDEN, C. W.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 3, pp 25-30, issn 0953-0673, 6 p.Article

Review article: management of peptic ulcer bleeding: the roles of proton pump inhibitors and Helicobacter pylori eradicationHOLTMANN, G; HOWDEN, C. W.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 19, Num 1, pp 66-70, issn 0953-0673, 5 p.Article

Non-steroidal anti-inflammatory drugs: who should receive prophylaxis?HAWKEY, C. J.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 2, pp 59-64, issn 0953-0673, 6 p.Conference Paper

Inflammatory bowel disease - An update on its etiopathogenesis, clinical presentation and treatmentDIGNASS, A; GOEBELL, H.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, issn 0953-0673, 112 p.Serial Issue

Systemic and topical steroids in inflammatory bowel diseaseSCHÖLMERICH, J.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 66-74, issn 0953-0673, 9 p.Article

The management of mild to severe acute ulcerative colitisTRAVIS, S. P. L.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 88-92, issn 0953-0673, 5 p.Article

Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors: overview and clinical implicationsROBINSON, M.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 6, pp 1-10, issn 0953-0673, 10 p.Article

A focused review of issues related to night-time reflux: a physician's resource for improving GERD managementSHAKER, R.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 9, issn 0953-0673, 85 p.Serial Issue

Review article: serotonin receptors and transporters: roles in normal and abnormal gastrointestinal motilityGERSHON, M. D.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 3-14, issn 0953-0673, 12 p.Article

Review article: the safety profile of tegaserodSCHOENFELD, P.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 7, pp 25-30, issn 0953-0673, 6 p.Article